Target intelligence / Profile preview

ribosomal protein L17 pseudogene 14 (RPL17P14)

Target
RPL17P14
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L17 pseudogene 14 (RPL17P14) is one of the many processed pseudogenes generated from the functional ribosomal protein L17 (RPL17) gene and is located in the human genome[6][11]. Pseudogenes like RPL17P14 typically do not encode functional proteins and lack biological activity as enzymes, transporters, receptors, or other canonical drug targets[8][9]. They are related by sequence to true ribosomal protein genes but usually result from gene duplication or retrotransposition events and accumulate mutations rendering them inactive[9]. Ribosomal protein L17 pseudogenes, including RPL17P14, are not characterized as therapeutic targets or associated with disease mechanisms, and no approved drugs or clinical safety concerns relate to them. In functional studies, research instead focuses on the parent gene, RPL17, which encodes a protein component of the large 60S ribosomal subunit involved in protein synthesis[1][6][13].

Other names
RPL17_8_331RPL17P14
02

Mechanism of action

None

03

Biological functions

Other (Pseudogenes do not encode functional proteins but may play roles in gene regulation or genome structure; there is no direct evidence of function reported for this specific pseudogene)
04

Disease associations

Other (No disease associations or roles are reported for this pseudogene; the functional RPL17 gene has relevance to disorders, but not this pseudogene)
05

Safety considerations

None
06

Interacting drugs

None (No drugs are known to act on pseudogenes)
07

Biomarkers

None

Beyond the preview

Go deeper on ribosomal protein L17 pseudogene 14 (RPL17P14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L17 pseudogene 14 (RPL17P14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call